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Cdc2 Phosphorylation of BAD Links
the Cell Cycle to the Cell Death Machinery
in neurons, leading to the entry of calcium into neurons
(Catterall, 2000).
Accumulating evidence suggests that activation of
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components of the cell cycle in postmitotic neurons2 Program in Neuroscience
might contribute to neuronal apoptosis (Liu and Greene,Harvard Medical School
2001). The induction of proteins that control the G1/S200 Longwood Avenue
transition in proliferating cells occurs in dying neuronsBoston, Massachusetts 02115
(Freeman et al., 1994; Kranenburg et al., 1996), and G1
cyclin-dependent kinases appear to trigger neuronal cell
death (Park et al., 1997, 1998). While the role of G1 cellSummary
cycle proteins in neuronal apoptosis is beginning to be
characterized, the role of G2/M cell cycle proteins, if any,A mechanism that triggers neuronal apoptosis has
in apoptosis of postmitotic neurons remained unknown.been characterized. We report that the cell cycle-regu-
Similarities in the morphological appearance of apo-lated protein kinase Cdc2 is expressed in postmitotic
ptotic cells to proliferating cells undergoing mitosis sug-granule neurons of the developing rat cerebellum and
gest that the mechanisms that regulate mitosis play athat Cdc2 mediates apoptosis of cerebellar granule
role in apoptosis (King and Cidlowski, 1995). Consistentneurons upon the suppression of neuronal activity.
with this idea, the cell cycle-regulated protein kinaseCdc2 catalyzes the phosphorylation of the BH3-only
Cdc2 has been implicated in apoptosis of proliferatingprotein BAD at a distinct site, serine 128, and thereby
cells (Shi et al., 1994; Yu et al., 1998). However, the roleinduces BAD-mediated apoptosis in primary neurons
of Cdc2 in promoting apoptosis of postmitotic neuronsby opposing growth factor inhibition of the apoptotic
and the mechanisms by which Cdc2 might promote apo-effect of BAD. The phosphorylation of BAD serine 128
ptosis in proliferating cells or postmitotic neurons re-inhibits the interaction of growth factor-induced serine
mained unknown.136-phosphorylated BAD with 14-3-3 proteins. Our re-
Studies of apoptosis suggest that members of thesults suggest that a critical component of the cell cycle
Bcl-2 family of proteins act as gatekeepers of the cellcouples an apoptotic signal to the cell death machin-
death machinery (Chao and Korsmeyer, 1998; Reed,ery via a phosphorylation-dependent mechanism that
1997; Thompson, 1995). Proapoptotic members of themay generally modulate protein-protein interactions.
Bcl-2 family of proteins induce the release of cyto-
chrome c from mitochondria, leading to the Apaf-1-Introduction
dependent activation of Caspase 9 and consequent in-
duction of a caspase cascade that executes the cellDuring the development of the mammalian nervous sys-
death program (Green and Reed, 1998; Thornberry andtem, neurons are generated in excess, and their num-
Lazebnik, 1998). In recent years, progress has beenbers are thus controlled by apoptotic cell death to en-
made in our understanding of the intracellular signalingsure the proper wiring of the nervous system (Lewin and
mechanisms by which cell surface death receptors acti-Barde, 1996). Electrical activity and polypeptide growth
vate the cell death machinery and the mechanisms byfactors are thought to be major regulators of neuronal
which survival factors suppress the cell death machinerycell death and survival (Franklin and Johnson, 1992;
(Ashkenazi and Dixit, 1998; Downward, 1998). However,Lewin and Barde, 1996). However, the mechanisms that
the mechanisms by which components of the cell cycle
drive neurons toward apoptosis in the absence of elec-
machinery might activate the cell death machinery re-
trical activity or growth factors remain incompletely un-
mained to be characterized.
derstood. In this study, we have investigated the role of Cdc2
Within the developing brain, neuronal apoptosis and in neuronal apoptosis. We have found that Cdc2 is ex-
survival have been extensively investigated in the cere- pressed in newly generated postmitotic granule neurons
bellar cortex (Williams and Herrup, 1988). Cerebellar in the rat cerebellum. Neuronal activity deprivation stim-
granule cell precursors differentiate into postmitotic ulates the activity of Cdc2 in granule neurons, and once
neurons within the external granular layer (EGL) and activated, Cdc2 triggers neuronal apoptosis. We have
then migrate inward within the cerebellar cortex into the also characterized a mechanism by which Cdc2 medi-
internal granular layer (IGL) where they mature (Altman ates activity deprivation-induced neuronal apoptosis.
and Bayer, 1997). Newly generated granule neurons un- Our results suggest that Cdc2 induces the phosphoryla-
dergo apoptosis in the EGL and IGL (Wood et al., 1993). tion of the BH3-only protein BAD at the distinct site of
Apoptosis of cultured cerebellar granule neurons is sup- serine 128, which lies near the growth factor-regulated
pressed by growth factors and neuronal activity, the site of phosphorylation, serine 136. The Cdc2-induced
latter mimicked by membrane-depolarizing concentra- phosphorylation of BAD at serine 128 inhibits the ability
tions of KCl (D’Mello et al., 1997; Miller and Johnson, of 14-3-3 proteins to sequester growth factor-induced
1996; Padmanabhan et al., 1999). Membrane depolariza- serine 136-phosphorylated BAD and thus promotes the
tion activates voltage-sensitive calcium channels (VSCCs) apoptotic effect of BAD by opposing growth factor inhi-
bition of BAD-mediated apoptosis. These results sug-
gest that a critical component of the cell cycle directly3 Correspondence: azad_bonni@hms.harvard.edu
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Figure 1. The Cell Cycle Regulatory Protein Cdc2 Is Expressed in Newly Generated Cerebellar Granule Neurons
(A) Cerebella of P6 rat pups were subjected to indirect immunofluorescence with no primary antibody (a), a mouse monoclonal antibody to
Cdc2 (b), a rabbit antibody to Cdc2 (c and g), or a mouse monoclonal antibody to the protein TAG-1 (h). Sections were also stained with a
DNA dye to visualize cells (d–f). (i) represents the merging of (g), (h), and an image of cells stained with the DNA dye.
(B) Granule neurons (P61DIV) were subjected to indirect immunofluorescence with a rabbit antibody to Cdc2 in the absence (a) or presence
of blocking peptide (Santa Cruz) (b), with the rabbit antiserum to Cdc2 (e and g) together with the antibody to TAG-1 (f) or a mouse monoclonal
antibody to the neuron-specific  tubulin (TuJ1) (h), or with a mouse monoclonal antibody to Cyclin B1 (i) together with a rabbit antibody to
the neuron-specific protein MAP2 (j). (c) and (d) are Hoechst images corresponding to (a) and (b). Arrowheads indicate examples of cells
expressing both Cdc2 and TAG-1, both Cdc2 and the neuron-specific -tubulin, or both Cyclin B1 and MAP2.
activates the cell death machinery in postmitotic neu- The expression of Cdc2 in postmitotic neurons led us
rons. In addition, our results point to a phosphorylation- to examine if Cdc2 becomes activated in neurons upon
dependent mechanism that may generally modulate exposure to an apoptotic stimulus. Expression of the
protein-protein interactions. Cdc2 activator Cyclin B1 was found in granule neurons
by immunoblotting and immunocytochemical analyses
of P6 cerebellar cultures (Figures 1B and 2A). Cyclin B1Results
interacted physically with Cdc2 in neurons, as deter-
mined in coimmunoprecipitation experiments (FigureCdc2 Mediates Apoptosis of Cerebellar Granule
2A). A larger amount of Cdc2 associated with CyclinNeurons upon Activity Deprivation
B1 in granule neuron cultures that were deprived ofTo investigate the role of Cdc2 in cerebellar granule
membrane depolarizing concentrations of KCl (5 mMneuron apoptosis, we first characterized the expression
KCl plus serum) than in cultures that were maintainedof Cdc2 in the rat cerebellar cortex. Cdc2 immunoreac-
in full medium (30 mM KCl plus serum), reflecting in parttivity, as detected by two antibodies that recognize dis-
the increased amount of total Cdc2 in granule neuronstinct epitopes on Cdc2, was found throughout the EGL
upon KCl withdrawal (Figure 2A). Consistent with thesein postnatal day 6 (P6) rat cerebellum, including cells
results, KCl withdrawal induced the activity of Cdc2 inthat expressed the protein TAG1, a marker of newly
granule neurons, as determined by assaying the kinasegenerated granule neurons residing in the EGL (Figure
activity that was immunoprecipitated from lysates of1A). Less intense Cdc2 immunoreactivity was also found
granule neuron cultures with an antibody to Cyclin B1in the IGL of P6 rat pups (Figure 1A). To confirm that
(Figure 2B) or with an antibody to Cdc2 (Figure 2C).Cdc2 is expressed in postmitotic neurons, we character-
Because the Cdc2-related kinase Cdk5 is expressed inized the expression of Cdc2 in granule neurons that
postmitotic neurons, including cerebellar granule neu-were cultured from P6 rat pups. Specific Cdc2 immuno-
rons (Ohshima et al., 1999; Tsai et al., 1993), we con-reactivity was found in newly generated granule neurons
firmed that the antibodies to Cdc2 used in our studythat expressed the neuron-specific protein -tubulin
recognize Cdc2 specifically and do not recognize Cdk5type III or the protein TAG-1 (Figure 1B). These results
by immunoblotting of lysates of 293T cells overexpress-indicate that Cdc2 is expressed in postmitotic cerebellar
ing Cdc2 or Cdk5 (Figure 2D). Together, these resultsgranule neurons at the time that developmentally-regu-
lated apoptosis peaks in vivo (Wood et al., 1993). indicate that the apoptosis-inducing stimulus of sup-
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Since roscovitine can also inhibit the Cdc2-related
kinases Cdk2 and Cdk5, we determined in transfection
experiments if a dominant interfering form of Cdc2 that
specifically inhibits Cdc2, Cdc2-DN (van den Heuvel and
Harlow, 1993), suppresses KCl withdrawal-induced neu-
ronal apoptosis. We found that Cdc2-DN, when ex-
pressed in granule neurons, blocked KCl withdrawal-
induced neuronal apoptosis (Figure 3C). KCl deprivation
induced an 70% reduction in the survival of vector-
transfected neurons at 3 days following transfection
(Figure 3C). However, KCl deprivation induced only a
10% reduction in the survival of Cdc2-DN-expressing
neurons at 3 days after transfection (Figure 3C). By con-
trast to Cdc2-DN, a dominant interfering form of Cdk2,
Cdk2-DN (van den Heuvel and Harlow, 1993), or a domi-
nant interfering form of Cdk5, Cdk5-DN (Tsai et al., 1994),
when expressed in granule neurons (Figure 3D), failed
to protect neurons against KCl withdrawal-induced apo-
ptosis (Figure 3D). Taken together, our results indicate
that among Cdc2-related kinases, Cdc2 selectively me-
diates activity withdrawal-induced neuronal apoptosis.
We also examined the role of Cdc2 in neuronal apo-
ptosis by reducing the expression of Cdc2 in cerebellar
granule neurons. An antisense Cdc2 oligonucleotide,
but not a corresponding control oligonucleotide, effec-
tively reduced the expression of Cdc2 in granule neurons
and blocked activity deprivation-induced apoptosis ofFigure 2. The Apoptosis-Inducing Stimulus of Neuronal Activity
Deprivation Induces Cdc2 Expression and Activity granule neurons (Figure 3E). The antisense Cdc2 oligo-
(A) Lysates of granule neuron cultures (P62DIV) that had been nucleotide reduced activity deprivation-induced apo-
maintained in full medium (30 mM KCl plus serum) or deprived of ptosis of granule neurons by 67%, whereas the corre-
KCl (5 mM KCl plus serum) for 24 hr were immunoblotted with a sponding control oligonucleotide reduced apoptosis by
mouse monoclonal antibody to Cyclin B1 (top panel), the rabbit anti-
only 16% (Figure 3E). Therefore, on the basis of resultsbody to Cdc2 (middle panel), or immunoprecipitated with the anti-
from three distinct methods of Cdc2 blockage, our re-body to Cyclin B1 followed by immunoblotting with the rabbit
sults suggest that endogenous Cdc2 plays a criticalantibody to Cdc2 (bottom panel). Lysates of granule neuron cultures
were immunoprecipitated with an antibody to Cyclin B1 (B) or with role in mediating apoptosis of newly generated neurons
a rabbit antibody to Cdc2 (C) and then subjected to an in vitro kinase upon activity deprivation.
assay using histone H1 as substrate. The activity of Cdc2 in granule
neurons was induced 2  0.5-fold (n  7, p  0.05, t test) in (B) and
Cdc2 Promotes Neuronal Apoptosis via thewas induced 1.6 0.1-fold (n 5, p 0.05, t test) in (C). (D) Lysates
Phosphorylation and Activation of BADof 293T cells that were transfected with an expression plasmid en-
coding Cdc2, Cdk2, or Cdk5, or their control plasmid were immu- Since Cdc2 is a protein kinase, we considered the possi-
noblotted with the mouse monoclonal antibody to Cdc2, the rabbit bility that Cdc2 might promote neuronal apoptosis upon
antibody to Cdc2, a rabbit antibody to Cdk2, or a mouse monoclonal activity deprivation by directly phosphorylating and
antibody to Cdk5.
thereby activating a component of the cell death ma-
chinery. The BH3-only protein BAD promotes apoptosis
by inhibiting the prosurvival Bcl-2 proteins (Gross et al.,pression of neuronal activity triggers the activation of
endogenous Cdc2 in cerebellar granule neurons. 1999). Growth factors and neurotrophins promote cell
survival in part by triggering the phosphorylation of BADTo determine the importance of KCl withdrawal-
induced Cdc2 in mediating neuronal apoptosis, we at serines 136 and 112, thereby inducing the sequestra-
tion of BAD with members of the 14-3-3 family of pro-blocked the function of endogenous Cdc2 in cerebellar
granule neurons. Because Cdc2 is enriched in newly teins (Blume-Jensen et al., 1998; Bonni et al., 1999; Datta
et al., 1997; del Peso et al., 1997; Zha et al., 1996). Wegenerated granule neurons (Figure 1), we analyzed cell
survival in P6 plus 2 days in vitro (P62DIV) cultures reasoned that in addition to linking survival signals to the
cell death machinery, BAD might be directly regulated bythat were exposed to full medium or that were deprived
of membrane depolarization (5 mM KCl plus serum). KCl protein kinases that propagate apoptotic signals.
Recombinant Cyclin B/Cdc2 induced the robust phos-withdrawal stimulated the cleavage and activity of the
protease Caspase 3 in granule neuron cultures and in- phorylation of recombinant BAD or GST-BAD fusion pro-
tein in in vitro kinase assays (Figure 4A). There are threeduced apoptosis of granule neurons (Figures 3A and
3B). However, incubation of granule neurons with the potential sites of Cdc2-induced phosphorylation in
mouse BAD, threonine 3, serine 128, and threonine 208.Cdc2 inhibitor roscovitine inhibited KCl withdrawal in-
duction of Caspase 3 cleavage and activation and gran- The Cdc2-induced phosphorylation of GST-BAD was
reduced dramatically when BAD serine 128 was mutatedule neuron apoptosis (Figures 3A and 3B). Together,
these results suggest that Cdc2 mediates KCl with- to alanine (GST-BADS128A), and it was abolished when
all three sites were mutated to alanine (GST-BAD2T/drawal-induced granule neuron apoptosis.
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Figure 3. Cdc2 Mediates Apoptosis of Cerebellar Granule Neurons upon the Suppression of Neuronal Activity
(A) Survival of granule neurons (P62DIV) that were in full medium or deprived of activity in the presence of roscovitine (10 M) or its vehicle
(DMSO) for the indicated times. KCl deprivation significantly reduced neuronal survival in control cultures beyond 24 hr (mean  SEM, n  3;
p  0.0001, ANOVA), but not in roscovitine-treated cultures (n  3).
(B) Lysates of granule neurons that were maintained in full medium or deprived of activity for 2 days were subjected to immunoblotting with
an antibody that specifically recognizes the cleaved form of Caspase 3 or were subjected to a fluorometric Caspase 3 assay (Clonetech).
Caspase measurements represent the average of two independent experiments.
(C) Cerebellar granule neurons (P62DIV) were transfected with a dominant interfering form of Cdc2 (Cdc2-DN) or its control expression
vector together with an expression plasmid encoding -galactosidase. Cultures were returned to full medium overnight, were switched to full
medium or deprived of KCl, and 1 or 2 days later subjected to indirect immunofluorescence with a monoclonal antibody to -galactosidase.
Activity deprivation reduced significantly the survival of neurons transfected with the control plasmid (n  3; ANOVA, p  0.001) but not
neurons transfected with the Cdc2-DN plasmid.
(D) Granule neurons were transfected with a dominant interfering form of Cdk2 (Cdk2-DN), a dominant interfering form of Cdk5 (Cdk5-DN),
or their control vector. Transfected cultures were analyzed as in (C). Cdk2-DN and Cdk5-DN failed to protect neurons against apoptosis in
activity-deprived cultures. Expression of Cdk2-DN in transfected granule neurons was confirmed by indirect immunofluorescence with an
antibody to HA, as the Cdk2-DN is HA-tagged. Expression of Cdk5-DN was confirmed with an antibody to Cdk5.
(E) Granule neurons (P62DIV) were maintained in full medium or deprived of KCl in the absence or presence of an antisense Cdc2 oligonucleo-
tide or a corresponding scrambled control oligonucleotide. The antisense Cdc2 oligonucleotide, but not the control oligonucleotide, significantly
reduced granule neuron apoptosis upon KCl withdrawal (ANOVA, p  0.01; n  3). Immunoblotting with the mouse monoclonal antibody to
Cdc2 confirmed that the antisense Cdc2 oligonucleotide specifically reduced Cdc2 expression in granule neurons.
Cdc2 Phosphorylates and Activates BAD
1009
Figure 4. Cdc2 Catalyzes the Phosphoryla-
tion of BAD at Serine 128 In Vitro and In Vivo
(A) Recombinant BAD was subjected to an in
vitro kinase assay in the absence (lane 1) or
presence of recombinant Cyclin B/Cdc2 (lane
2). Recombinant GST, GST-BAD, or GST-
BAD mutants, in which potential Cdc2 phos-
phorylation sites were replaced with alanine,
were subjected to an in vitro kinase assay
with Cyclin B/Cdc2 (lanes 3–6). Phosphory-
lated BAD or GST-BAD was separated by
PAGE and analyzed by autoradiography.
(B) GST, GST-BAD, or GST-BADS128A was
subjected to an in vitro kinase assay with
Cyclin B/Cdc2 and immunoblotted with the
phospho128-BAD antibody (lanes 1–3) or
with a rabbit antibody that recognizes BAD
regardless of its phosphorylation state (C-20;
lanes 4–6).
(C) Recombinant BAD was subjected to an in
vitro kinase assay with Cyclin B/Cdc2 or PKA,
and immunoblotted with the phospho128-
BAD antibody, a phospho112-BAD antibody,
a phospho136-BAD antibody, or the C-20
BAD antibody.
(D) Lysates of COS cells that were transfected
with BAD together with Cyclin B and Cdc2 or
Cdc2-DN or their control expression vectors
were immunoblotted with the phospho128-
BAD antibody or the C-20 BAD antibody.
S128A) (Figure 4A). We focused on the Cdc2-induced induced BAD serine 128 phosphorylation was blocked
by roscovitine (Figure 5B), suggesting that Cdc2 medi-phosphorylation of serine 128, because serine 128 is
conserved across several species and the amino acid ates KCl withdrawal-induced phosphorylation of BAD
serine 128. We also found that blockage by nimodipinesequence encompassing serine 128 conforms most to
the sequence preferred by Cdc2 as a substrate (Holmes of L-type VSCCs in membrane-depolarized granule neu-
rons (Catterall, 2000) induced the expression of Cdc2and Solomon, 1996).
We raised a rabbit antiserum that specifically recog- and the phosphorylation of BAD at serine 128 (Figure
5C), suggesting that the inhibition of calcium entry innizes BAD when BAD is phosphorylated at serine 128.
The phospho128-BAD antibody recognized BAD or granule neurons activates the Cdc2-BAD pathway.
A specific phospho128-BAD signal was also detectedGST-BAD that was phosphorylated by Cyclin B/Cdc2,
but did not recognize unphosphorylated BAD, unphos- immunocytochemically in granule neurons that were de-
prived of membrane depolarization (Figure 5D), thusphorylated GST-BAD, or GST-BADS128A that was incu-
bated with Cyclin B/Cdc2 (Figures 4B and 4C). In addi- allowing, in transfection experiments, the direct assess-
ment of Cdc2’s role in the phosphorylation of BAD serinetion, the phospho128-BAD antibody did not recognize
BAD that was phosphorylated in vitro at serine 112 or 128 in granule neurons. KCl withdrawal induced serine
128 phosphorylation of endogenous BAD in a large frac-136 by PKA (Figure 4C), and Cdc2 did not induce the
phosphorylation of BAD at serine 112 or serine 136 (Fig- tion of vector-transfected granule neurons (Figures 5E
and 5F). By contrast, the dominant interfering form ofure 4C). These results establish the specificity of the
phospho128-BAD antibody and that Cdc2 catalyzes the Cdc2, Cdc2-DN, when expressed in granule neurons,
blocked KCl withdrawal-induced serine 128 phosphory-phosphorylation of BAD at the distinct site of serine 128
in vitro. In other experiments, we found that Cyclin B lation of endogenous BAD (Figures 5E and 5F). Taken
together, our results suggest that endogenous Cdc2and Cdc2 but not Cdc2-DN, when expressed in COS
cells together with BAD, induced the phosphorylation mediates the phosphorylation of endogenous BAD at
serine 128 in cerebellar granule neurons upon activityof BAD at serine 128 (Figure 4D), demonstrating the
ability of Cdc2 to induce the phosphorylation of BAD at deprivation.
To determine the functional effect of the Cdc2-inducedserine 128 in cells.
We next investigated if Cdc2 triggers the phosphoryla- phosphorylation of BAD at serine 128 in neurons, we
first used an assay established to measure the apoptotiction of BAD that is expressed at normal levels in primary
neurons. Consistent with the hypothesis that BAD might effect of BAD that is exogenously expressed in granule
neurons (Bonni et al., 1999; Datta et al., 1997). We trans-be a physiological substrate of Cdc2, endogenous Cdc2
and endogenous BAD in cerebellar granule neurons fected newly generated granule neurons with an expres-
sion plasmid encoding BAD alone or together with ex-were found to interact physically (Figure 5A). Immu-
noblotting experiments revealed that KCl withdrawal in- pression plasmids encoding Cyclin B and Cdc2. One
day after transfection, cultures were deprived of survivalduced the robust phosphorylation of BAD at serine 128
in granule neurons (Figure 5B). The KCl withdrawal- medium or were treated with a high concentration of
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Figure 5. Cdc2 Mediates the Phosphorylation of Endogenous BAD at Serine 128 in Neurons
(A) Lysates of P62DIV granule neurons were immunoprecipitated with the monoclonal antibody to Cdc2 or no antibody, and then were
immunoblotted with the rabbit antibody to Cdc2, a rabbit antibody to BAD that recognizes BAD regardless of its phosphorylation state (N-20),
or with a rabbit antibody to Bax. Cdc2 interacts with BAD but not with Bax in granule neurons.
(B) Lysates of granule neurons (P62DIV) that had been maintained in full medium or deprived of KCl and incubated with roscovitine (10 M)
or its vehicle (DMSO) for 24 hr were immunoblotted with the phospho128-BAD antibody or the C-20 BAD antibody. The BAD antibodies
recognized full-length and BAD-related proteins of lower molecular weight (BADr) that may represent cleavage products of BAD.
(C) Lysates of granule neurons that were in full medium or deprived of KCl and incubated with nimodipine (20 M) or its vehicle (DMSO) were
subjected to immunoblotting with the mouse monoclonal antibody to Cdc2, the phospho128-BAD antibody, or the N-20 BAD.
(D) Granule neurons that were in full medium (a and b) or deprived of KCl for 24 hr (c–h) were subjected to indirect immunofluorescence with
the phospho128-BAD antibody (left panels) and Hoechst (right panels). The KCl withdrawal-induced phospho128-BAD signal (c) was competed
by phosphorylated BAD serine 128 peptide (e) but not by unphosphorylated BAD serine 128 peptide (g).
(E) Granule neurons (P62DIV) were transfected with Cdc2-DN or its control expression plasmid together with -galactosidase. After overnight
incubation with full medium, cultures were switched to full medium or deprived of KCl, and 24 hr later, they were subjected to indirect
immunofluorescence with the phospho128-BAD antibody and the mouse monoclonal antibody to -galactosidase. Shown from KCl-deprived
cultures are examples of a phospho128-BAD-positive granule neuron transfected with control vector (a and b) and a phospho128-BAD-
negative neuron transfected with Cdc2-DN (c and d).
(F) Quantitation of the experiment described in (E). KCl withdrawal induced a large increase in the percentage of transfected neurons that
were phospho128-BAD positive in vector-transfected (n 3; p 0.0001, ANOVA) but not in Cdc2-DN-transfected neurons. For each condition,
at least 200 transfected neurons were counted.
insulin, which activates the IGF1 receptor, and 8 hr later, in which serine 128 was replaced with an alanine
(BADS128A). While Cyclin B/Cdc2 antagonized IGF1 re-cultures were analyzed for the presence of apoptosis in
transfected neurons. The measurement of apoptosis 8 ceptor inhibition of wild-type BAD, Cyclin B/Cdc2 failed
to block the ability of the IGF1 receptor to inhibit thehr following survival factor deprivation allowed the as-
sessment of the apoptotic effect of exogenous BAD in apoptotic effect of BADS128A (Figure 6A). Taken to-
gether, these results suggest that the Cdc2-inducedneurons, because activation of the endogenous Cdc2-
BAD apoptotic pathway begins peaking 1–2 days follow- phosphorylation of BAD at serine 128 promotes the apo-
ptotic effect of BAD in cerebellar granule neurons bying activity deprivation (Figures 3A and 5, and data not
shown). The expression of BAD induced apoptosis of opposing growth factor inhibition of BAD.
To determine if the Cdc2-induced serine 128 phos-transfected newly generated granule neurons that were
deprived of survival factors, and activation of the IGF1 phorylation of BAD that is expressed endogenously in
granule neurons promotes apoptosis, we tested if a mu-receptor inhibited BAD-mediated apoptosis (Figure 6A).
Cyclin B/Cdc2, when coexpressed with BAD, did not tant allele of BAD serine 128, when expressed in granule
neurons, can act in a dominant-negative manner to in-augment BAD-mediated apoptosis in cultures that were
deprived of survival factors. However, we found that hibit activity deprivation-induced neuronal apoptosis.
We reasoned that full-length BAD mutants, when over-Cyclin B/Cdc2 blocked the ability of activated IGF1 re-
ceptor to inhibit the apoptotic effect of BAD (Figure 6A). expressed at levels that are required to dominantly in-
hibit the activity of endogenous BAD, might be toxicWe next determined the effect of Cdc2 on growth
factor inhibition of the apoptotic effect of a BAD mutant because of the potential of full-length BAD to titrate
Cdc2 Phosphorylates and Activates BAD
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Figure 6. Cdc2-Induced Phosphorylation of
BAD Serine 128 Promotes BAD-Mediated
Apoptosis by Antagonizing Growth Factor In-
hibition of BAD
(A) Granule neurons (P62DIV) were trans-
fected with Cyclin B and Cdc2 or their control
vector together with wild-type BAD or
BADS128A and -galactosidase. One day
after transfection, cultures were switched
from full medium to basal medium in the ab-
sence or presence of insulin (10 g/ml) to
activate the IGF1 receptor. After 8 hr, cultures
were subjected to indirect immunofluo-
rescence. Percent apoptosis is represented
as mean  SEM (n  4). Activation of the
IGF1 receptor reduced BAD-mediated apo-
ptosis in neurons transfected with the control
(ANOVA, p  0.001) but not in neurons trans-
fected with Cyclin B and Cdc2 plasmids.
Cyclin B/Cdc2 failed to reduce IGF1 recep-
tor suppression of the apoptotic effect of
BADS128A (ANOVA, p  0.001).
(B) Schematic of dominant-negative BAD ser-
ine 128A and its control. Green fluorescent
protein is fused at its C terminus to a 9 amino
acid BAD peptide encompassing serine 128,
in which serine 128 is wild-type (GFP-BADS128)
or in which serine 128 is replaced by an ala-
nine (GFP-BADS128A). GFP-BADS128 and
GFP-BADS128A were expressed at equiva-
lent levels in transfected neurons.
(C) Granule neurons were transfected with the
GFP expression plasmid, GFP-BADS128, or
GFP-BADS128A together with an expression
plasmid encoding -galactosidase. Trans-
fected cultures were processed as in Figure
3C. KCl withdrawal induced a significant in-
crease in apoptosis of granule neurons trans-
fected with the control GFP or GFP-BADS128
(n 3; p 0.0001, ANOVA) but not in granule
neurons transfected with GFP-BADS128A.
(D) Granule neurons were transfected with
GFP-BADS128A or its control GFP expres-
sion plasmid together with -galactosidase.
Transfected cultures were then processed as
in Figures 5E and 5F. KCl withdrawal induced
a large increase in the percentage of trans-
fected neurons that were phospho128-BAD
positive in GFP-transfected neurons (n  3;
p  0.0001, ANOVA) but not in GFP-BADS128A-transfected neurons. For each condition, at least 200 transfected neurons were counted.
(E) Granule neurons were maintained in full medium or deprived of neuronal activity in the absence or presence of an antisense BAD
oligonucleotide or a corresponding scrambled control oligonucleotide. The antisense BAD oligonucleotide, but not the control oligonucleotide,
significantly reduced granule neuron apoptosis upon KCl withdrawal (ANOVA, p  0.01; n  3). Immunoblotting with the N-20 BAD antibody
revealed that the antisense BAD oligonucleotide specifically reduced the expression of BAD.
prosurvival proteins via its BH3 domain and BAD serines reduce the KCl withdrawal-induced phosphorylation of
endogenous BAD (Figure 6D). Together, these results112 and 136. Therefore, in designing a dominant-nega-
tive BAD serine 128 mutant allele, we constructed a suggest that GFP-BADS128A acts in a dominant-nega-
tive manner to inhibit the endogenous Cdc2-BAD apo-gene encoding green fluorescent protein fused at its C
terminus to a 9 amino acid BAD peptide encompassing ptotic pathway in neurons upon the suppression of
neuronal activity. However, in addition to inhibiting en-serine 128 (GFP-BADS128) or an identical peptide in
which serine 128 was replaced with an alanine (GFP- dogenous BAD, GFP-BADS128A might prevent neu-
ronal apoptosis by inhibiting Cdc2 activation of otherBADS128A) (Figure 6B).
In transfection experiments, GFP-BADS128 and GFP- substrates that remain to be identified.
The dominant-negative GFP-BADS128A findings wereBADS128A were expressed at equivalent levels in gran-
ule neurons, as determined by visualization of GFP (Fig- supported by additional experiments in which we found
that an antisense oligonucleotide to BAD, but not a cor-ure 6B). GFP-BADS128A, but not GFP-BADS128, when
expressed in granule neurons, reduced significantly ac- responding control oligonucleotide, reduced both the
level of BAD expression in granule neurons and KCltivity deprivation-induced apoptosis (Figure 6C). In other
experiments, GFP-BADS128A was found to significantly withdrawal-induced granule neuron apoptosis (Figure
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apoptotic effect of BAD or BADS128A, IGF1 receptor6E). Taken together, our findings suggest that the Cdc2-
activation failed to suppress the apoptotic effect ofinduced phosphorylation of endogenous BAD at serine
BADS128D (Figure 7C), indicating that BADS128D mim-128 is required for the ability of the suppression of neu-
ics the function of the Cdc2-induced phosphorylatedronal activity to promote the apoptotic effect of BAD.
BAD in vivo. Consistent with the idea that BAD acts
downstream of Cdc2, the dominant interfering form ofThe Serine 128 Phosphorylation of BAD Inhibits
Cdc2 (Cdc2-DN), when expressed in granule neuronsthe Interaction of Serine 136-Phosphorylated
together with BADS128D, failed to protect neurons fromBAD with 14-3-3 Proteins
BADS128D-induced apoptosis (data not shown). Re-We next investigated the mechanism by which the BAD
placement of BAD serine 128 by aspartate had little ef-serine 128 phosphorylation promotes apoptosis. BAD
fect on the phosphorylation of BAD at serine 136 or serinelies at the junction of prosurvival protein kinase cas-
112 in vitro (Figure 7D), suggesting that BADS128D op-cades and the cell death machinery. The protein kinases
poses growth factor inhibition of BAD at a step thatAkt, p21-activated kinase 1 (PAK1), and pp70S6 kinase
follows the phosphorylation of BAD at serine 136. Inmediate survival factor-induced phosphorylation of BAD
other control experiments, wild-type BAD, BADS128D,serine 136 (Blume-Jensen et al., 1998; Datta et al., 1997;
and BADS128A were found to be expressed at equiva-del Peso et al., 1997; Harada et al., 2001; Schurmann
lent levels in transfected neurons or COS cells (Figureet al., 2000). On the other hand, the protein kinases
7D). We next compared in transfected COS cells theRsk, PKA, and PAK1 mediate survival factor-induced
ability of BAD, BADS128A, or BADS128D to interact withphosphorylation of BAD serine 112 (Bonni et al., 1999;
14-3-3 that was tagged with the FLAG epitope (FLAG-Harada et al., 1999; Schurmann et al., 2000; Shimamura
14-3-3). We found that wild-type BAD or BADS128Aet al., 2000; Tan et al., 1999). The phosphorylation of BAD
coimmunoprecipitated with FLAG-14-3-3 (Figure 7E).at serines 136 and 112 culminates in the sequestration of
However, BADS128D failed to effectively coimmuno-phosphorylated BAD by members of the 14-3-3 family
precipitate with FLAG-14-3-3 (Figure 7E), suggestingof proteins (Zha et al., 1996).
that the phosphorylation of BAD serine 128 inhibits theWe focused on how the Cdc2-induced serine 128
interaction of BAD with 14-3-3. In other experiments,phosphorylation of BAD antagonizes growth factor inhi-
BAD but not BADS128A, when coexpressed with Cyclinbition of BAD. Growth factor inhibition of BAD in granule
B and Cdc2 in COS cells, interacted less effectivelyneurons appears to be mediated by the Akt-induced
with 14-3-3 proteins (Figure 7F). Taken together, thesephosphorylation of BAD at serine 136 (Datta et al., 1997).
results suggest that the Cdc2-induced phosphorylationIn in vitro kinase assays, the prior Cdc2-induced phos-
of BAD at serine 128 inhibits the ability of 14-3-3 proteinsphorylation of BAD at serine 128 did not reduce the Akt-
to interact with serine 136-phosphorylated BAD in vivo.induced phosphorylation of BAD at serine 136 (Figure
We next determined if the Cdc2-induced phosphory-7A), suggesting that the phosphorylation of BAD at ser-
lation of BAD that is endogenously expressed in granuleine 128 does not interfere with the ability of Akt to access
neurons triggers the dissociation of BAD from endoge-BAD serine 136 as a substrate.
nous 14-3-3 proteins. The association of endogenous
We next determined if the Cdc2-induced phosphory-
BAD and endogenous 14-3-3 proteins was observed
lation of BAD at serine 128 inhibits the sequestration of
by coimmunoprecipitation in granule neurons that were
serine 136-phosphorylated BAD by 14-3-3 proteins. In
maintained in full medium (Figure 7G). However, the
a GST pull-down assay, recombinant BAD, when un-
amount of 14-3-3 that coimmunoprecipitated with BAD
phosphorylated or when phosphorylated at serine 128 was reduced in lysates of granule neurons that were
by Cdc2, did not coprecipitate with a GST-14-3-3 fusion deprived of neuronal activity (Figure 7G). Importantly,
protein (Figure 7B). However, BAD, when phosphory- roscovitine prevented the reduction in the amount of
lated at serine 136 by Akt, coprecipitated with GST-14- BAD-14-3-3 protein complex in granule neurons upon
3-3 (Figure 7B). By contrast, BAD, when phosphory- KCl withdrawal (Figure 7G), suggesting that activity dep-
lated at both serines 128 and 136 by Cdc2 and Akt, rivation induces the Cdc2-mediated dissociation of the
respectively, coprecipitated less effectively with GST- BAD-14-3-3 protein complex.
14-3-3 (Figure 7B). In other experiments, His-tagged We next determined if activity deprivation might in-
14-3-3, when captured on Ni2-NTA agarose beads, duce the dephosphorylation of BAD at serine 136 or
coprecipitated effectively both GST-BAD and GST- serine 112, an event that might be expected to further
BADS128A that were phosphorylated by Akt (Figure 7B). contribute to the dissociation of the BAD-14-3-3 protein
However, 14-3-3 coprecipitated less effectively GST- complex. Interestingly, KCl withdrawal had little effect
BAD that was phosphorylated with both Cdc2 and Akt on the phosphorylation of endogenous BAD at serine
(Figure 7B). By contrast, Cdc2 had little effect on the 136 and serine 112 (Figure 7H), reflecting the continued
ability of Akt-phosphorylated GST-BADS128A to copre- presence of growth factors in the medium. In addition,
cipitate with 14-3-3 (Figure 7B). Together, these in vitro the inhibition of BAD serine 128 phosphorylation by ros-
results suggest that the Cdc2-induced phosphorylation covitine had little effect on the BAD serine 136 or serine
of BAD at serine 128 interferes with the interaction of 112 phosphorylation (Figure 7H). Together, these results
14-3-3 proteins with serine 136-phosphorylated BAD. suggest that the Cdc2-induced phosphorylation of BAD
To facilitate our investigations of the effect of the BAD at serine 128 mediates the activity deprivation-induced
serine 128 phosphorylation on the interaction of serine dissociation of the endogenous BAD-14-3-3 protein
136-phosphorylated BAD with 14-3-3 proteins in vivo, complex in granule neurons.
we replaced BAD serine 128 with aspartate (BADS128D) The activity deprivation-induced dissociation of BAD
to mimic serine 128-phosphorylated BAD. In granule from 14-3-3 proteins raised the possibility that a larger
amount of BAD might be available to interact with theneurons, while IGF1 receptor activation inhibited the
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Figure 7. The Cdc2-Induced Phosphorylation of BAD Serine 128 Inhibits the Interaction of Growth Factor-Induced Serine 136-Phosphorylated
BAD with 14-3-3 Proteins
(A) Prior phosphorylation of BAD at serine 128 does not reduce Akt-induced phosphorylation of BAD at serine 136. Increasing amounts of
BAD (0.05 g, lanes 1 and 4; 0.1 g, lanes 2 and 5; 0.25 g, lanes 3 and 6) were subjected to an in vitro kinase assay with Cyclin B/Cdc2
followed by Akt. In vitro kinase reaction products were immunoblotted with a phospho128-BAD antibody, a phospho136-BAD antibody, or
the C-20 BAD antibody.
(B) BAD was subjected to an in vitro kinase reaction with Cdc2, Akt, or both kinases, and then was incubated with GST-14-3-3. Supernatant
and precipitated fractions were immunoblotted with the C-20 BAD or phospho128-BAD antibody. In the experiments shown in the right panel,
GST-BAD or GST-BADS128A was incubated with or without Cdc2 and then phosphorylated by Akt and incubated with His-14-3-3 and Ni-
NTA agarose beads. Precipitated proteins were immunoblotted with the BAD-C20 antibody or a mouse monoclonal antibody to 14-3-3.
(C) Granule neurons were transfected with wild-type BAD, BADS128D, or BADS128A together with -galactosidase. Cultures were then
processed as in Figure 6A. Activation of the IGF1 receptor reduced the apoptotic effect of BAD and BADS128A (ANOVA, p  0.01) but not
of BADS128D.
(D) Left panel: granule neurons were transfected with HA-tagged BAD, HA-BADS128A, HA-BADS128D, or their control expression plasmid
(0.5 g/well) together with -galactosidase and Bcl-2 to protect neurons against apoptosis. Transfected neurons were subjected to indirect
immunofluorescence with the antibody to -galactosidase and a rabbit antibody to HA. Middle panel: lysates of COS cells that were transfected
with BAD, BADS128A, BADS128D, or their control vector were immunoblotted with the C-20 BAD antibody. Right panel: GST-BAD or GST-
BADS128D was subjected to an in vitro kinase assay with PKA and immunoblotted with the C-20 BAD, phospho112-BAD, or phospho136-
BAD antibody.
(E) COS cells were transfected with BAD alone or together with 14-3-3 tagged with the FLAG epitope, or BADS128A, or BADS128D together
with FLAG-14-3-3. Lysates of transfected cells were immunoprecipitated with an antibody to FLAG followed by immunoblotting with the
N-20 BAD antibody.
(F) COS cells were transfected with BAD or BADS128A together with FLAG-14-3-3 and cyclin B and Cdc2 or the kinase-inactive Cdc2-DN.
Lysates of transfected cells were immunoprecipitated with the C-20 BAD antibody and then immunoblotted with the 14-3-3 antibody.
(G) Lysates of granule neurons were immunoprecipitated with no antibody or with the C-20 BAD antibody followed by immunoblotting with
the 14-3-3 antibody.
(H) Lysates of granule neurons were immunoblotted with the phospho128-BAD, phospho136-BAD, phospho112-BAD, or the N-20 BAD antibody.
(I) Lysates of granule neurons were immunoprecipitated with the C-20 BAD antibody followed by immunoblotting with an antibody to Bcl-xl.
prosurvival Bcl-2 proteins in granule neurons upon activ- that Cdc2 mediates the activity deprivation-induced dis-
sociation of the BAD-14-3-3 protein complex and theity deprivation. In coimmunoprecipitation experiments,
a pool of endogenous BAD was found in a protein com- concomitant increased association of the BAD-Bcl-xl
protein complex.plex with endogenous Bcl-xl in granule neurons that
were maintained in full medium (Figure 7I). In contrast
to the KCl withdrawal-induced dissociation of the BAD- Discussion
14-3-3 protein complex in neurons, KCl withdrawal in-
duced a modest roscovitine-sensitive increase in the In this study, we have identified a direct link between a
component of the cell cycle and the cell death machineryamount of Bcl-xl coprecipitating with BAD in granule
neurons (Figure 7I). Taken together, our findings suggest in postmitotic neurons. Our results suggest that the criti-
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cal component of the cell cycle machinery Cdc2 is tion of 14-3-3 proteins with their phosphoserine 136
ligand. Beyond BAD, our observations point to a mecha-coopted by newly generated postmitotic neurons to ac-
tivate cell death upon the suppression of neuronal activ- nism by which the phosphorylation of proteins in prox-
imity to the phosphorylated serine ligands of 14-3-3ity. We have found that Cdc2 catalyzes the phosphoryla-
tion of the BH3-only protein BAD at the distinct site of proteins may negatively modulate the interaction of 14-
3-3 proteins with their binding proteins.serine 128, thereby activating BAD-mediated apoptosis
by inhibiting the sequestration of growth factor-induced In newly generated neurons, we have found that neu-
ronal activity inhibits the Cdc2-induced phosphorylationserine 136-phosphorylated BAD by members of the 14-
3-3 family of proteins. Thus, our results suggest that of BAD at serine 128, while growth factors and neuro-
trophins induce the phosphorylation of BAD at theCdc2 promotes neuronal apoptosis by antagonizing
growth factor-induced signals that suppress the cell neighboring serines 136 and 112 (Bonni et al., 1999;
Datta et al., 1997). Together, these modifications pro-death machinery.
The established role of Cdc2 is to drive proliferating mote BAD’s interaction with 14-3-3 proteins. These find-
ings illustrate how neuronal activity, growth factors, andcells through the G2/M transition of the cell cycle. Sur-
prisingly, we found that Cdc2 is expressed in newly neurotrophins cooperate to effectively suppress a com-
ponent of the cell death machinery. In the future, it willgenerated postmitotic neurons and that Cdc2 plays a
critical role in triggering neuronal apoptosis. These find- be important to characterize signaling mechanisms by
which neuronal activity suppresses the Cdc2-BAD apo-ings are consistent with the hypothesis that reactivation
of components of the cell cycle in postmitotic cells in- ptotic pathway.
Recent studies suggest that in addition to the roleduces cell death (Liu and Greene, 2001). In proliferating
cells, the regulation of Cdc2 expression and activity has of the cell cycle in developmentally regulated neuronal
apoptosis, components of the cell cycle machinery arebeen well characterized (Coleman and Dunphy, 1994;
Lees, 1995). How Cdc2 expression and activity are in- activated in degenerating neurons in the adult brain (Vin-
cent et al., 1997). It will be interesting to determine ifduced in postmitotic neurons by apoptosis-inducing
stimuli and whether such regulation recapitulates as- the Cdc2-BAD apoptotic pathway contributes to neu-
ronal cell death in neurodegenerative diseases of thepects of Cdc2’s regulation in proliferating cells will be
the subject of future studies. brain.
The identification of the BH3-only protein BAD as a
Experimental Proceduresphysiological substrate of Cdc2 provides a direct link
between a component of the cell cycle and the cell death
Antibodies
machinery. BAD appears to be the target of several Antibodies to Cdc2 (mouse monoclonal and rabbit polyclonal),
protein kinases that suppress BAD’s apoptotic function Cyclin B1, Cdk2, Cdk5 (rabbit polyclonal), BAD (C-20 and N-20),
(reviewed in Gross et al., 1999) (Bonni et al., 1999; Tan Bax, and 14-3-3 were obtained from Santa Cruz Biotechnology
(Santa Cruz, CA). The antibody to Bcl-xl (UBI, Lake Placid, NY), theet al., 1999; Shimamura et al., 2000; Schurmann et al.,
mouse monoclonal antibody to -galactosidase (Promega, Madi-2000; Lizcano et al., 2000). On the other hand, death-
son, WI), FLAG (Sigma, St. Louis, MO), and cleaved Caspase 3inducing stimuli have been suggested to promote BAD-
(Cell Signaling, Beverly, MA) were also purchased. The rabbit anti-
mediated apoptosis by inducing the dephosphorylation body to phosphorylated serine 128 BAD was generated by inject-
of BAD at these sites (Ayllon et al., 2000; Wang et al., ing New Zealand rabbits with the phosphopeptide antibody
1999). Our finding that Cdc2 mediates neuronal apopto- C-EGMEEELpSPFRGRS as described (Bonni et al., 1999).
sis by inducing the phosphorylation of BAD at serine
Transfections128 suggests that the apoptotic function of BAD can be
Cerebellar granule neurons were prepared and transfected as de-activated, rather than just suppressed, in a phosphoryla-
scribed (Bonni et al., 1999), with the following modifications: 35 l
tion-dependent manner. In future studies, it will be im- of the DNA-calcium phosphate precipitate was added per well in a
portant to determine if Cdc2 directly activates other 24-well plate containing 7  105 cerebellar granule cells and left on
BH3-only proteins or other components of the cell death the cells for 15 min. In the experiments shown in Figure 3C, cultures
were transfected with 0.5 g of test plasmid together with 0.25 gmachinery in a phosphorylation-dependent manner. It
of the -galactosidase expression plasmid per well of a 24-wellwill be also important to determine if BAD serine 128
plate. In the experiments shown in Figure 6C, each well was trans-is the target of other protein kinases that propagate
fected with 1.0 g of GFP-BAD or GFP-BADS128A and 0.25 g ofapoptotic signals. the -galactosidase expression plasmid. In the experiments shown
That the Cdc2-induced phosphorylation of BAD at in Figure 6A, each well was transfected with 0.75 g of Cyclin B,
serine 128 regulates the interaction of growth factor- 0.75 g of Cdc2, 0.05 g of BAD or BADS128A, and 0.25 g of the
-galactosidase expression plasmid. Cell survival and death wereinduced serine 136-phosphorylated BAD with 14-3-3
assessed in -galactosidase-expressing neurons based on the in-proteins illuminates a specific mechanism that underlies
tegrity of neurites and integrity of the nucleus as determined by thethe dynamic interplay of proapoptotic and prosurvival
DNA dye bisbenzimide (Hoechst 33258). Indirect immunofluores-signaling pathways in cells. Structural data suggest that
cence was carried out as described (Bonni et al., 1999). Cell counts
14-3-3 protein dimers engage in a bidentate interaction were carried out in a blinded manner by two observers. In our trans-
with phosphorylated serines 136 and 112 of BAD (Yaffe fection experiments, Tuj-1-positive granule neurons accounted for
99.1%  0.3%, and GFAP-positive astrocytes accounted for onlyet al., 1997). The location of serine 128 in the vicinity of
0.7% 0.7% of transfected -galactosidase-expressing cells (n 3).serine 136 together with our in vitro data suggest that
COS cells were transfected by a calcium phosphate method asthe phosphorylation of serine 128 interferes sterically
described (Bonni et al., 1999).with the interaction of 14-3-3 proteins with serine 136-
phosphorylated BAD. However, the possibility remains Biochemical Assays
that within cells, serine 128-phosphorylated BAD inter- Immunoprecipitation and immunoblotting were carried out as de-
scribed (Bonni et al., 1999). In vitro kinase assays were carried outacts with another protein that then disrupts the interac-
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as described in the New England Biolabs protocol for the Cdc2 Downward, J. (1998). Ras signalling and apoptosis. Curr. Opin.
Genet. Dev. 8, 49–54.kinase product. GST pull-down assays were done as described (Zha
et al., 1996). Franklin, J.L., and Johnson, E.M., Jr. (1992). Suppression of pro-
grammed neuronal death by sustained elevation of cytoplasmic cal-
Antisense Oligonucleotides cium. Trends Neurosci. 15, 501–508.
A phosphorothioate antisense Cdc2 oligonucleotide designed to
Freeman, R.S., Estus, S., and Johnson, E.M., Jr. (1994). Analysis of
hybridize to nucleotides	10 to10 relative the translation initiation
cell cycle-related gene expression in postmitotic neurons: selective
site of rat Cdc2 or a corresponding scrambled control oligonucleo-
induction of Cyclin D1 during programmed cell death. Neuron 12,
tide, or a phosphorothioate antisense BAD oligonucleotide designed
343–355.
to nucleotides 	11 to 8 or a corresponding scrambled control
Green, D.R., and Reed, J.C. (1998). Mitochondria and apoptosis.oligonucleotide was synthesized (Invitrogen, Carlsbad, CA) and
Science 281, 1309–1312.added to granule neurons cultures at 10 M (Cdc2) or 5 M (BAD).
At P62DIV, cultures were deprived of neuronal activity (5 mM KCl Gross, A., McDonnell, J.M., and Korsmeyer, S.J. (1999). BCL-2 family
plus serum). After 2 days, cultures were fixed and cell death was members and the mitochondria in apoptosis. Genes Dev. 13, 1899–
assessed. 1911.
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